Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Align Technology, Inc.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

West Pharmaceutical Services, Inc.

Align Technology is a global medical device company that develops and manufactures orthodontic and restorative treatment systems, including clear aligners and intraoral scanners, for dental practices worldwide.

Align Technology

We are dedicated to transforming lives by improving the journey to a healthy, beautiful smile.
 
Discover your straight path to a bright future at Align Technology. As a part of our smart, diverse and fast-moving global team, you'll make an impact on the market leader that's moving an industry forward. 
 
Want to find out what's next for us—and for you? Follow us on LinkedIn for business updates and check out our current opportunities at www.aligntech.com/careers. 
 
25 years ago, we pioneered the market for clear aligners. Since then, we have continuously innovated with new products and technologies that revolutionize treatments for doctors and their patients. Today, doctors and labs in over 100 markets use the Invisalign system, iTero intraoral scanners and exocad software to improve smiles for patients – from simple tooth alignment to complex corrections, kids to adults, orthodontics to multi-disciplinary restorative treatment. 
 
Learn more about Align Technology and our products: 
www.aligntech.com
www.invisalign.com
www.itero.com
www.exocad.com


Registered Dental Hygienists are critical team members in a dental practice.

Recently, Align Technology was at the 2024 RDH Under One Roof meeting in Aurora, Colorado to demo the Tero Lumina™ intraoral scanner and share the latest #AlignTech chairside tools to support patient education. We were thrilled for the opportunity to speak with RDH attendees about resources to support elevated patient conversations and deliver exceptional care.

#RDHUOR #AlignTech #Invisalign #iTero #exocad

With the iTero Lumina™ scanner, simplify patient record-taking like never before. Say goodbye to intraoral photos and hello to photorealistic 3D models that offer unparalleled detail and clarity.

Hear Dr. David R. Boschken, D.M.D. of Boschken Orthodontics share his experience with the new iTero Lumina scanner featuring iTero Multi-Direct Capture™ technology.​⁣

Experience the future of dental imaging and optimize your practice's efficiency and accuracy: 🔗 https://bit.ly/49ktnET

#AlignTech #iTero #Invisalign #exocad

Congratulations to Julie Coletti, #AlignTech EVP, chief legal and regulatory officer, for being listed as one of the Most Influential Women in Arizona Business for 2024 by AZ Big Media in recognition of her leadership and industry influence. 👏 🎉

Read more here: https://bit.ly/3Sfzioa 

#Invisalign #iTero #exocad

Happy National Intern Day🎉 – especially to our amazing #AlignTech summer interns! We are grateful for the enthusiasm and insights of these early career professionals and proud to have them on the #AlignTech team as we transform smiles and change lives.

Curious about life as an intern at Align Technology? Meet Ryan Skabelund, a data analytics intern on the Customer Success team, as he shares a typical day working at our Tempe, Arizona global headquarters. 👋

To learn more about our #AlignTech Early Talent programs, visit: https://bit.ly/3NfCPNC

#NationalInternDay #Invisalign #exocad #iTero #AlignIntern #ProudAlignIntern

We had a great time at the American Academy of Clear Aligners Annual Conference (AACA), where we showcased the latest #AlignTech innovations to transform smiles and change lives.

Thank you to the doctors and their team members who stopped by to meet with us!

#Invisalign #iTero #exocad

Happy #WorldEmojiDay! Did you know that you can accessorize Invisalign® clear aligners with decorative Invisalign Stickables™and show your favorite emojis? 

Comment below which Invisalign Stickables™ emoji is your favorite! We'll go first, ours is 😁.

#AlignTech #Invisalign #exocad #iTero

Metric
Company Name	Align Technology, Inc.	West Pharmaceutical Services, Inc.
Symbol	ALGN	WST
MSH ID	COM:ALIGNTECH	COM:WESTPHARMA
Market	STOCKS	STOCKS
Sector	Healthcare	Healthcare
Industry	Medical - Devices	Medical - Instruments & Supplies
Country	US	US
Stage
Employee Count	21.67K	10.60K
Website	aligntech.com	westpharma.com
LinkedIn	align-technology
Founders

Metric
Market Cap	18.75B	23.41B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	3.86B	2.95B
Revenue (LTM)
Revenue (NTM)
Gross Profit	2.71B	1.13B
EBITDA	643.34M	875.70M
Operating Income	643.34M	676M
Net Income	445.05M	593.40M
EPS	5.82	7.98
Diluted EPS	5.81	7.88
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.70	0.38
Operating Profit Margin	0.17	0.23
EBITDA Margin	0.17	0.30
Net Profit Margin	0.12	0.20
Return on Equity	0.12	0.21
Return on Assets	0.08	0.16
Return on Capital Employed	0.17	0.22

COM:ALIGNTECH

Align Technology

Last Close

228.21

22/11 21:00

Market Cap

18.75B

Beta: -

Volume Today

795.99K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	46.94	52.81
P/B Ratio	5.75	10.30
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	6.15	9.76
EV Multiple	38.23	34.90

Metric
Days Sales Outstanding	85.38	64.74
Days Payables Outstanding	35.74	44.24
Days Inventory Outstanding	94.07	87.15
Operating Cycle	195.74	150.56
Cash Conversion Cycle	159.65	104.66
Asset Turnover	0.64	0.82

Metric
Operating Cash Flow	785.78M	776.50M
Free Cash Flow	608.06M	414.50M
Cash Flow to Debt	6.21	3.31
Operating Cash Flow/Sales	0.20	0.26
Free Cash Flow Yield	0.03	0.01

Metric
Cash & Equivalents	937.44M	853.90M
Accounts Receivable	-104.61M	4M
Inventory	296.90M	434.70M
Goodwill	419.53M	108.50M
Debt to Capitalization	0.05	0.10
Debt to Assets	0.04	0.08
Current Ratio	1.18	3.70
Quick Ratio	1.09	2.03

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.03	0.01
R&D to Revenue	0.09	0.02
SG&A to Revenue